Next Gen Nutrition Investment Partners & Dunedain Ventures Invests in Bonumose Inc.
Accelerates Scale Up of Disruptive, Affordable, Healthy Sweetener
Next Gen Nutrition Investment Partners LLC and Dunedain Ventures LLC announced an investment in Bonumose LLC, a food ingredient and enzyme innovation company focused on cost efficient production of “healthy rare sugars”.
Bonumose has developed and patented the methods for continuous production of high-purity rare sugars – such as tagatose and allulose – from low-cost, plant-based feedstocks at 5x greater yield than available methods. Bonumose’s patented processes make possible the global mass-market adoption of healthy, great-tasting, fully functional rare sugars. Rare sugars have the potential to significantly disrupt the global sweetener market in both consumer and processed food applications. Bonumose’s lead products, tagatose and allulose, taste like sugar, have significantly fewer calories than normal sugar, have negligible glycemic index, are non-cariogenic and perform like normal sugar in major applications such as baking, confectionary, beverages, and frozen desserts. These rare sugars are well known by the global food industry, but prior to Bonumose’s patented technology and process, they were never cost effective enough for widespread application which can disrupt the sweetener market and have a meaning impact on human health
Bonumose also can upcycle by-product/side stream starch left over from its supply chain partners’ food production. Beyond food ingredients, Bonumose’s enzyme technology can deliver cost advantaged ingredient solutions for dietary supplements, crop protection, animal nutrition, and other industries.
Other investors in this round include iSelect, ASR Group, and the Hershey Company. Ed Rogers, Bonumose CEO explained, “We are happy to have NGN and Dunedain Ventures as part of our investor base and appreciate their experience and support in helping Bonumose make a positive impact on the world”.
Next Gen Nutrition Investment Partners invests in early and growth-stage companies in the food and beverage sector, focusing on businesses offering superior nutrition and a reduced impact to the planet, including branded food and beverages, food tech and superior food ingredients. As former consumer product executives with extensive experience in the food and beverage industry, the firm’s principals’ operational expertise will help these companies deliver superior business results and better returns for investors. “Bonumose is a perfect fit with our investment thesis in that it can have significant societal level positive health outcomes by allowing widespread access to fundamentally healthier sweeteners than those available in the market today”, said NGN partner Jim Cali.
NGN partnered with Dunedain Ventures to bring investors together for the Bonumose opportunity. Dunedain Managing Partner James Shifren said, “Bonumose is an exciting investment opportunity for our investors who are focused great companies leading innovation in large trends, such as health and wellness. We are looking forward to partnering with NGN to find more leading-edge opportunities, like Bonumose, in the future.” Dunedain Ventures is an early-stage investor with a passion for working with founders and entrepreneurs to create lasting value and help make the world a better place.